review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.UCL.2005.08.004 |
P698 | PubMed publication ID | 16291033 |
P50 | author | Rena R. Wing | Q28007338 |
P2093 | author name string | Stephen Schneider | |
Raymond C Rosen | |||
Noel Gendrano | |||
P2860 | cites work | Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries | Q33211753 |
The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey | Q33770714 | ||
Sexual dysfunction in the United States: prevalence and predictors | Q33852255 | ||
Erectile dysfunction | Q33942524 | ||
Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial | Q33979308 | ||
The worldwide prevalence and epidemiology of erectile dysfunction | Q34062787 | ||
Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. | Q34548848 | ||
Prevalence of erectile dysfunction: a systematic review of population-based studies. | Q35031368 | ||
Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator | Q35068163 | ||
Obesity, the metabolic syndrome, and sexual dysfunction. | Q36132007 | ||
Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). | Q36144545 | ||
Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. | Q39571055 | ||
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction | Q39742696 | ||
Physiology of penile erection | Q40576740 | ||
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission | Q41082098 | ||
Health-related quality of life in men with erectile dysfunction | Q41190819 | ||
Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study | Q42622330 | ||
Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate | Q43752204 | ||
Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. | Q44281791 | ||
Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction | Q44297429 | ||
Sexual function in men older than 50 years of age: results from the health professionals follow-up study | Q44537490 | ||
Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms | Q44762856 | ||
Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study | Q44849135 | ||
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population | Q49323666 | ||
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. | Q50951063 | ||
Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. | Q51075422 | ||
Increased incidence of depressive symptoms in men with erectile dysfunction. | Q51990033 | ||
Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. | Q52378491 | ||
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). | Q53295449 | ||
Health-related quality of life in a UK-based population of men with erectile dysfunction. | Q53316927 | ||
On life satisfaction in male erectile dysfunction. | Q53589971 | ||
Decline of sexual function with age in japanese men compared with american men—results of two community-based studies | Q57540430 | ||
Sexual function of men ages 40 to 79 years: the Olmsted County Study of Urinary Symptoms and Health Status Among Men | Q57540572 | ||
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study | Q72641848 | ||
Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study | Q73192554 | ||
Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity | Q73764160 | ||
Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study | Q73839388 | ||
Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study | Q73866764 | ||
Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? | Q74107646 | ||
The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study | Q77115570 | ||
Relation of erectile dysfunction to angiographic coronary artery disease | Q78772913 | ||
P433 | issue | 4 | |
P921 | main subject | epidemiology | Q133805 |
erectile dysfunction | Q184674 | ||
comorbidity | Q1414874 | ||
P304 | page(s) | 403-17, v | |
P577 | publication date | 2005-11-01 | |
P1433 | published in | Urologic Clinics of North America | Q15767454 |
P1476 | title | Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors | |
P478 | volume | 32 |
Q36717888 | A study of sexuality and health among older adults in the United States |
Q34286254 | A web-based survey of erection hardness score and its relationship to aging, sexual behavior, confidence, and risk factors in Japan |
Q39479659 | Allergic rhinitis and risk of erectile dysfunction--a nationwide population-based study. |
Q35762331 | Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility |
Q34624315 | Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction |
Q36861695 | Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction |
Q33629535 | Clinical characteristics of older male military veterans seeking treatment for erectile dysfunction |
Q47108557 | Comparison of the effects of extracorporeal shock wave therapy and a vacuum erectile device on penile erectile dysfunction: a randomized clinical trial |
Q36542984 | Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys |
Q82860997 | Determinants of erectile dysfunction in type 2 diabetes |
Q33534054 | Determinants of male reproductive health disorders: the Men in Australia Telephone Survey (MATeS). |
Q46571184 | Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction |
Q33752512 | Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score? |
Q38415580 | Effects of Omega-3 Fatty Acids on Erectile Dysfunction in a Rat Model of Atherosclerosis-induced Chronic Pelvic Ischemia |
Q35702929 | Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial |
Q84970233 | Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those with Underlying Conditions: An Integrated Analysis of Two Pivotal Trials |
Q62029106 | Erectile dysfunction |
Q58466592 | Erectile dysfunction after prostatectomy: An evaluation of the risk factors |
Q36628792 | Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference |
Q36474164 | Erectile dysfunction and mortality |
Q37109366 | Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial |
Q34498189 | Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177 |
Q35013746 | Exploring the Sexuality of African American Older Women |
Q34966026 | Factors influencing older black women's sexual functioning and their disclosure of sexual concerns |
Q37974638 | Fertility and the aging male. |
Q41729921 | Genetic aspects of erectile dysfunction |
Q26737722 | Modifying Risk Factors in the Management of Erectile Dysfunction: A Review |
Q97895149 | Organic Diet and Intermittent Fasting are Associated with Improved Erectile Function |
Q58136480 | Predictors of Quality of Life, Sexual Intercourse, and Sexual Satisfaction among Active Older Adults |
Q40723709 | Sexual Function and Mortality in Older Men: The Concord Health and Ageing in Men Project. |
Q39014560 | Sexual dysfunction and dissatisfaction in chronic hepatitis C patients |
Q37163654 | Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort |
Q53082231 | Significant improvement of erectile function after Roux-en-Y gastric bypass surgery in obese Chinese men with erectile dysfunction. |
Q28082929 | The concept of lifestyle factors, based on the teaching of avicenna (ibn sina) |
Q38128169 | The impact of obesity on benign and malignant urologic conditions |
Q33571010 | Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence |
Search more.